MHRC Research Seminar: Future Treatment of Mood Disorders

MHRC Research Seminar PosterProf Allan YOUNG 2000 x 1050 pxv2

Add to Calendar

Date

11 Sep 2024
Organiser

Mental Health Research Centre, Co-organiser: Department of Rehabilitation Sciences
Time

14:00 - 15:30
Venue

Hybrid Mode: AG204, Podium Level, Chung Sze Yuen Building, PolyU & Online via Zoom

Enquiry

Ms Carol Yau 2766 4445 carol-mui.yau@polyu.edu.hk

Remarks

Registration starts at 1:45 p.m.

Summary

Enjoy free admission, all are welcome.

* Seats are limited and will be allocated on a 'first in, first served' basis.
* Online link will be provided if the seats are full.
* Please note that NO Physiotherapy (PT) and Occupational Therapy (OT) CPD points will be offered by the research seminar.

Topic
Future Treatment of Mood Disorders

Abstract
Mood disorders are a common, chronic, severe, complex and costly group of recurrent psychiatric illness that can be devastating for the affected individual and their families. There is a significant clinical need for more effective and better tolerated drug treatments for mood disorders. Although the pathophysiology and neurobiological processes responsible for mood disorders are not fully understood, a greater understanding of the causative underlying mechanisms is gradually emerging. Future advances are expected based on the ability to manipulate and redress the fundamental disease processes and neurobiological dysfunction that underlie these disorders.

Speaker
Professor Allan YOUNG
Head of School
Academic Psychiatry
King's College London
United Kingdom

Biography

Professor Allan Young is the Chair of Mood Disorders and Director of the Centre for Affective Disorders at King's College London, UK. He has held academic positions at renowned institutions such as Oxford University, Newcastle University, University of British Columbia, and Imperial College London. With a focus on severe psychiatric illnesses, particularly mood disorders, Professor Young has received research funding from prestigious organizations including the UK Medical Research Council, the Wellcome Trust, and the National Institutes of Health. He has authored over 300 peer-reviewed publications and notable books on psychopharmacology and affective disorders. He holds leadership roles in professional societies and is currently the President of the International Society for Affective Disorders.

Previous Event Next Event